Entera Bio shareholders approve 2.5x increase in authorized shares to 350M and 2.5M share increase in equity plan

Entera Bio Ltd.

Authorized ordinary shares increased from 140,010,000 to 350,000,000 effective July 14, 2026.
2018 Equity Incentive Plan amended to add 2,500,000 ordinary shares for issuance.
All director nominees elected: Sean Ellis, Steven D. Rubin, Geno H. Germano (Class III, three-year terms).
Shareholders approved non-executive director compensation, share-based grants, and advisory say-on-pay.
Kesselman & Kesselman (PwC) ratified as independent auditor for FY 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.